NewsBenzingaMilestone Pharmaceuticals : le BPA du T3 à (0,18 $) dépasse l’estimation de (0,21 $), le chiffre d’affaires de 2,963 M$ dépasse l’estimation de 1,143 M$ Milestone Pharmaceuticals : le BPA du T3 à (0,18 $) dépasse l’estimation de (0,21 $), le chiffre d’affaires de 2,963 M$ dépasse l’estimation de 1,143 M$ Benzinga 2026.11.13 11:54 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3